Description

Shenzhen YHLO Biotech Co., Ltd., based in Shenzhen, China, specializes in the research, production, and sale of in-vitro diagnostic (IVD) instruments and reagents primarily within the Chinese market. The company offers essential diagnostic tools that provide crucial insights for medical conditions spanning autoimmune diseases, reproductive health, and infectious illnesses. Its comprehensive product line includes a range of immunoassay platforms like chemiluminescence (CLIA), enzyme-linked immunosorbent assay (ELISA), and line immunoassay (LIA) systems, complete with their respective test panels and analyzers. Additionally, YHLO develops point-of-care (POCT) solutions, including immunofluorescence readers and test panels, alongside ESR analyzers. Notably, the firm also produces COVID-19 detection kits, which are exported to various international markets such as Germany, France, Italy, Denmark, and Sweden. Founded in 2008, Shenzhen YHLO Biotech Co., Ltd. maintains its headquarters in Shenzhen, China.